Protein	MEDICINE
S	MEDICINE
can	O
bind	O
to	O
negatively	O
charged	O
phospholipids	O
via	O
the	O
carboxylatedGla	O
domain	O
.	O
This	O
property	O
allows	O
Protein	MEDICINE
S	MEDICINE
to	O
function	O
in	O
the	O
removal	O
of	O
cells	O
which	O
are	O
under	O
going	O
apoptosis	O
.	O
Apoptosis	O
is	O
a	O
form	O
of	O
cell	O
death	O
that	O
is	O
used	O
by	O
the	O
body	O
to	O
remove	O
unwanted	O
or	O
damaged	O
cells	O
from	O
tissues	O
.	O
Cells	O
,	O
which	O
areapoptotic	O
,	O
no	O
longer	O
actively	O
manage	O
the	O
distribution	O
of	O
phospholipids	O
in	O
their	O
outer	O
membrane	O
and	O
hence	O
begin	O
to	O
display	O
negatively	O
charged	O
phospholipids	O
,	O
such	O
as	O
phosphatidyl	O
serine	O
,	O
on	O
thecell	O
surface	O
.	O
In	O
healthy	O
cells	O
,	O
an	O
ATP	O
dependent	O
enzyme	MEDICINE
removes	O
these	O
from	O
the	O
outer	O
leaflet	O
of	O
the	O
cell	O
membrane	O
.	O
These	O
negatively	O
charged	O
phospholipids	O
are	O
recognized	O
by	O
phagocytes	O
such	O
asmacrophages	O
.	O
Protein	MEDICINE
S	MEDICINE
can	O
bind	O
to	O
the	O
negatively	O
charged	O
phospholipids	O
andfunction	O
as	O
a	O
bridging	O
molecule	O
between	O
the	O
apoptotic	O
cell	O
and	O
the	O
phagocyte	O
.	O
The	O
bridging	O
property	O
of	O
Protein	O
S	O
enhances	O
the	O
phagocytosis	O
of	O
the	O
apoptotic	O
cell	O
,	O
allowing	O
it	O
to	O
be	O
removed	O
`	O
cleanly	O
'	O
without	O
any	O
symptoms	O
of	O
tissue	O
damage	O
such	O
as	O
inflammation	O
occurring	O
.	O
